| KYMRKymera Therapeutics, Inc. | 5,502,710 | $458.3M |
| MLTXMoonLake Immunotherapeutics | 16,001,284 | $298.3M |
| RVMDREVOLUTION MEDICINES, INC. | 2,856,782 | $277.8M |
| NKTRNEKTAR THERAPEUTICS | 2,559,595 | $184.2M |
| GPCRStructure Therapeutics Inc. | 3,459,358 | $166.7M |
| MIRMMirum Pharmaceuticals, Inc. | 1,584,727 | $146.4M |
| GHRSGH Research PLC | 8,650,158 | $121.6M |
| PVLAPALVELLA THERAPEUTICS, INC. | 960,989 | $119.8M |
| ZYMEZymeworks Inc. | 3,734,142 | $93.5M |
| XNCRXencor Inc | 7,133,720 | $86.0M |
| STOKStoke Therapeutics, Inc. | 2,547,557 | $82.9M |
| CGEMCullinan Therapeutics, Inc. | 5,750,683 | $81.7M |
| IRONDisc Medicine, Inc. | 1,272,312 | $81.4M |
| XOMAXOMA Royalty Corporation | 2,590,303 | $81.3M |
| OLMAOlema Pharmaceuticals, Inc. | 5,295,893 | $79.0M |
| TYRATyra Biosciences, Inc. | 1,976,196 | $75.7M |
| GLUEMonte Rosa Therapeutics, Inc. | 4,460,886 | $73.4M |
| ALKSAlkermes plc. | 2,000,000 | $70.7M |
| KURAKura Oncology, Inc. | 8,445,769 | $68.7M |
| ACIUAC Immune SA | 19,822,436 | $54.5M |
| CBIOCRESCENT BIOPHARMA, INC. | 2,748,763 | $50.5M |
| ANNXAnnexon, Inc. | 8,698,173 | $48.2M |
| CMPXCompass Therapeutics, Inc. | 7,764,842 | $41.1M |
| IMCRImmunocore Holdings plc | 1,294,463 | $39.0M |
| SEPNSepterna, Inc. | 1,353,249 | $32.5M |
| STROSUTRO BIOPHARMA, INC. | 1,251,788 | $31.2M |
| FHTXFoghorn Therapeutics Inc. | 5,842,000 | $27.9M |
| FDMT4D Molecular Therapeutics, Inc. | 2,879,289 | $26.8M |
| IVVDInvivyd, Inc. | 19,525,000 | $25.4M |
| AVTXAvalo Therapeutics, Inc. | 1,632,845 | $24.4M |
| ELDNEledon Pharmaceuticals, Inc. | 6,293,282 | $19.4M |
| XFORX4 Pharmaceuticals, Inc | 2,233,742 | $9.2M |
| OKUROnKure Therapeutics, Inc. | 1,978,972 | $8.2M |
| TCRXTScan Therapeutics, Inc. | 5,564,290 | $5.6M |
| IMAImageneBio, Inc. | 1,110,002 | $5.6M |
| MOLNMOLECULAR PARTNERS AG | 1,353,968 | $5.4M |
| IVAInventiva S.A. | 686,040 | $3.8M |